NSEInvestor Presentation21 Aug 2026 · 21 Aug 2026, 02:59 pm

Investor Presentation

Valiant Organics Limited · VALIANTORG

✦ AI SummaryResults

Valiant Organics Limited has informed the Exchange about Investor Presentation for the quarter ended June 30, 2026, with a copy hosted on the company's website.

Analysis Scores

Earnings Impact8/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk6/10
Liquidity Impact9/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Valiant Organics Limited has informed the Exchange about Investor Presentation

Attachments (1)

📄

VALIANTORG_21082026145906_Intimation_IP_June_2026.pdf

pdf

Download →
View document text
August 21, 2026 To, To, Listing / Compliance Department Listing / Compliance Department BSE LTD National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, Dalal Street G Block Bandra-Kurla Complex, Mumbai- 400 001 Bandra (E), Mumbai- 400 051. SCRIP CODE – 540145 SYMBOL- VALIANTORG Sub: Investors’ Presentation Dear Sir / Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Investors’ Presentation on the financial results of Valiant Organics Limited (the “Company”) for the quarter ended June 30, 2026. A copy of aforesaid Investor Presentation is also hosted on the website of Company www.valiantorganics.com. Please take the same on your records. Thanking you, Yours faithfully, For Valiant Organics Limited Kaustubh Kulkarni Company Secretary ICSI M. No.: A52980 Encl.: a/a Regd. Office:109, Udyog Kshetra, 1st Floor, Mulund Goregaon Link Rd, Mulund (W), Mumbai 400 080, Maharashtra, India. Corporate Office: 701-A, 7th Floor, Tower-B, Embassy 247, L.B.S. Road, Vikhroli (W), Mumbai - 400 083, Maharashtra, India. +91 22 6797 6683 • info@valiantorganics.com • www.valiantorganics.com CIN NO.: L24230MH2005PLC151348 Ea rnings Presentation | Q1-FY27 SNAPSHOT One of the largest chlorophenol One of the leading manufacturer of derivatives manufacturer globally Benzene derivatives products One of the largest domestic PNA One of the few commercial players in manufacturer Ortho Anisidine and Para Anisidine Diversified client base across Amongst 1st few domestic PAP Pharmaceuticals, Dyes & Pigments, Manufacturers Agrochemicals and specialty chemicals. 6 Manufacturing units across 5 Locations 5 Zero Liquid Discharge plants Total Production Capacity of 70,000 TPA 900+ Employees Company Overview Valiant Organics Limited was incorporated in 1984 by first generation technocrats and is headquartered out of Mumbai, India. The company is focused on the manufacturing and marketing of specialty chemicals which find usage in a variety of industries, including agrochemicals, pharmaceuticals, dyes, pigments, and veterinary medications. Key chemistries include Chlorination, Hydrogenation, Ammonolysis, Acetylation, Sulphonation, Methoxylation amongst others. Over the years the company has primarily focused on manufacturing specialty chemicals that have a high demand but low supply and are primarily dependent on imports. The company is listed on both the BSE and NSE with a market capitalization of INR ~ 7,545.68 Mn. as on 30th June 2026. Operating Revenue (INR Mn) and EBITDA Margin (%) FY26 Revenue Break-up – Chemistries FY26 Revenue Break-up – End user Industry Others, 6% 12000 10,518 50.00% 45.00% Pharmaceuticals; 10000 7,231 7,188 7,388 34 50 .. 00 00 %% Chlorination, Dyes & 21% 8000 30.00% 20% Pigments; 45% 6000 17.97% 25.00% Ammonolysis, 15.62% 11.94% 20.00% 26% Specialty 4000 2,315 15.00% 5.28% 7.47% Chemicals; 10% 2000 10.00% Agro 5.00% Hydrogenation, Chemicals; 0 0.00% 48% FY23 FY24 FY25 FY26 Q1-FY27 Revenue EBITDA Margin *Pursuant to the allotment of further equity shares through IPO by the Company's material step down subsidiary namely, Valiant Laboratories Limited ("VLL"), the stake of Company's subsidiary Dhanvallabh Ventures LLP in VLL has been diluted to 46.83% and accordingly VLL has ceased to be a step down subsidiary of the Company and has became an associate company w.e.f. October 04,2023. Hence, consolidated financial of previous periods and YTD results are not comparable. Valiant Organics Limited | Q1-2027 3 Chemistries And Product Basket Q1-FY27 Revenue Share Hydrogenation Ammonolysis Key Products: Industries Served: Key Products: • Ortho Anisidine Industries Served: • Dyes • Para Nitro Aniline • Para Anisidine • Dyes • Pigments • Ortho Chloro Para Nitro Aniline • IPPCA • Pigments • Pharmaceutical • Meta Chloro Aniline • Agro Chemicals • Para Amino Phenol 4 21% • Ortho Amino Phenol Others Acetylation Sulphonation Methoxylation 19% Chlorination Key Products: Key Products: Key Products: • 6 Acetyl OAPSA • OT5SA • Ortho Nitro Anisole Key Products: Industries Served: • OA Acetanilide • 4B Acid • Para Nitro Anisole • Para ChloroPhenol (PCP) • Agro Chemicals • PA Acetanilide • 2B Acid • Ortho ChloroPhenol (OCP) • Cosmetics 6% • 2,4 Di Chlorophenol (2,4 DCP) • Veterinary Industries Served: Industries Served: Industries Served: • 2,6 Di ChloroPhenol (2,6 DCP) • Pharmaceuticals • Dyes • Dyes • Dyes • 2,4,6 Tri ChloroPhenol (2,4,6 TCP) • Pigments • Pigments Valiant Organics Limited | Q1-2027 4 Manufacturing Footprint HYDROGENATION & METHOXYLATION- CHLORINATION – SARIGAM JHAGADIA UNIT 1 • Capacity: 18,000 MTPA • Capacity: 28,800 MTPA • Products: PCP, OCP, 2,4 DCP, 2,6 DCP, • Products: ONA/OA, PNA/PA, IPPCA, 2,4,6 TCP CONVERSION PRODUCTS HYDROGENATION – JHAGADIA UNIT 2 AMMONOLYSIS - VAPI • Capacity: 12,000 MTPA • Capacity: 10,000 MTPA • Products: PAP, PHARMA INTERMEDIATES • Products: PNA, OCPNA ACETYLATION & SULPHONATION – AMMONOLYSIS - TARAPUR AHMEDABAD • Capacity: 6,600 MTPA • Capacity: 1,800 MTPA • Products: PNA • Products: 6 ACETYL OAPSA, OA/PA ACETANILIDE, OT5SA Valiant Organics Limited | Q1-2027 5 Key Strengths Domain expertise and broad Plant locations are process understanding in a Wide supply chain strategically located near variety of chemistries. The provides the continuous ports to provide a executive team is made up of availability of adequate competitive advantage, first-generation technocrats and high-quality raw significant logistical cost with more than 50 years of materials and savings, and faster collective expertise. manufacturing. delivery times. Robust Strong Distinct Integrated Business Customer Product Operations Model Relations Portfolio Strategic Widespread Domain Location of Supply Chain Knowledge Plants Diverse product range Manufacturing a diverse Multi-use and backward Established multi-year and client base across range of intermediates integrated plants to relationships with clients in numerous industries and as well as value-added produce a wide range of both domestic and countries provides a products for a variety of products and tailor them to international markets due to sustainable business industries. meet the diverse needs, high-quality standards, model in multiple technical qualifications, innovative production chemistries by lowering batch sizes, and delivery capabilities. product, industry, and schedules of our clients. geographical risk. Valiant Organics Limited | Q1-2027 6 Q1-FY27 HIGHLIGHTS Valiant Organics Limited | Q1-2027 7 Q1-FY27 CONSOLIDATED FINANCIAL HIGHLIGHTS INR 2,315 Mn Operational Revenue INR 416 Mn Operating EBITDA 17.97% Operating EBITDA Margin INR 293 Mn Profit After Tax 12.66% PAT Margin INR 10.44/ Share Valiant Organics Limited | Q1-2027 8 Q1-FY27 Operational Highlights Q1-FY27 Revenue Break-up – Chemistries • Total Revenue grew 14% YoY to INR 2,342 million, marking the highest quarterly revenue Others, 6% in the last six quarters and a full recovery from the H1 FY26 trough. • Gross Profit Margin improved to 43% from 39% YoY, supported by a ~410 bps reduction Chlorination, in raw material consumption. Ammonolysis, • Raw Material Cost declined to 57% of sales from 61%, generating savings of ~INR 4 for 21% every INR 100 of revenue. Hydrogenation, • EBITDA margin expanded to 17.97%, the highest in the last six quarters, supported by operating leverage. • Employee and other expenses increased only 4.6% YoY, despite 14% revenue growth, Q1-FY27 Volume Break-up – Chemistries reflecting improved operating efficiency. Others, 5% • Finance cost declined 15% YoY to INR 51 million. Chlorination, Ammonolysis, Hydrogenation, 48% Valiant Organics Limited | Q1-2027 9 Key Chemistries Chlorination (INR Mn) Hydrogenation (INR Mn) Ammonolysis (INR Mn) Others (INR Mn) 1,272 1,400 533 163 460 451 1,200 1,082 1,050 55 34 00 11 68 00 140 S E44 45 00 431 1,000 55 12 00 140 U430 120 94 800 500 N420 490 475 [Showing first 8,000 characters — download PDF for full document]